2 completed, 1 unknown, 1 withdrawn. 4 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 4 | Completed 2, Unknown 1, Withdrawn 1 |
| Phase 3 | 1 | Unknown 1 |
Follow Placebo Device: new trials by email Literature Review of Placebo Device trials Research Report on Placebo Device
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Electromagnetic Fields Versus Placebo For Child-Pugh A and B Patients With Advanced Hepatocellular Carcinoma TheraBionic Device, Placebo Device, Quality of Life Assessment - Hepatocellular Carcinoma | Phase 2 / Phase 3 | Unknown | THERABIONIC INC. | 166 | 2023-07-01 | 2023-06-28 |
| Intrabucally Administered Electromagnetic Fields Versus Placebo as Third-line Therapy For Patients With Advanced Hepatocellular Carcinoma TheraBionic Device, Placebo Device - Hepatocellular Carcinoma | Phase 2 | Withdrawn | Wake Forest University Health Sciences | 2021-04-01 | 2021-02-26 | |
| Safety and Efficacy of a Drug Delivery System in Glaucoma High Dose Drug Device, Low Dose Drug Device, Placebo Device - Open-angle Glaucoma, Ocular Hypertension | Phase 2 | Completed | Vistakon Pharmaceuticals | 47 | 2009-10-01 | 2015-03-06 |
| Safety and Efficacy of a Glaucoma Drug Delivery System High Dose Device, Low Dose Device, Placebo Device - Glaucoma, Open-Angle, Ocular Hypertension | Phase 2 | Completed | Vistakon Pharmaceuticals | 55 | 2008-12-01 | 2015-03-06 |
Carcinoma, Hepatocellular (2) · Glaucoma, Open-Angle (2) · Ocular Hypertension (2)
Vistakon Pharmaceuticals (2) · THERABIONIC INC. (1) · Wake Forest University Health Sciences (1)
United States (4)
Valerie K Pasche, MD (1) · William Blackstock, MD (1)
P30CA012197 (1), R44CA256984 (1)